Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study

OBJECTIVE: To assess whether adding or switching to sulfonylureas is associated with an increased risk of myocardial infarction, ischaemic stroke, cardiovascular death, all cause mortality, and severe hypoglycaemia, compared with remaining on metformin monotherapy in patients with type 2 diabetes. D...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMJ
Hlavní autoři: Douros, Antonios, Dell’Aniello, Sophie, Yu, Oriana Hoi Yun, Filion, Kristian B, Azoulay, Laurent, Suissa, Samy
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group Ltd. 2018
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6050517/
https://ncbi.nlm.nih.gov/pubmed/30021781
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.k2693
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky